Skip to main content
Log in

Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis

  • Original article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Background

Ankylosing spondylitis (AS), a rheumatic disease, incapacitates human beings during the most productive stage of their lives, causes functional disturbances, and thus affects both patients and their relatives. Disease activity, functional impairment, and efficacy of treatment are affected by various environmental and genetic factors, one of which is smoking. We investigated smoking’s effect on clinical activity and functional impairment in AS.

Patients and methods

Forty-eight patients with back pain and limited movements, diagnosed with AS based on clinical, radiological, and laboratory examinations and referred to the Trakya University School of Medicine Physical Medicine and Rehabilitation Department in Turkey were included in this study. Disease activity was evaluated with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and functional impairment with the Bath Ankylosing Spondylitis Functional Index (BASFI). The Mann-Whitney U test was used to determine relationships between smoking and physical findings, laboratory results, and BASDAI and BASFI scores.

Results

Twenty-four patients were smokers. They had significantly higher BASDAI and BASFI scores and significantly lower forced vital capacity values than nonsmokers (P=0.000, P=0.002, and P=0.001, respectively) (Mann-Whitney U test).

Conclusion

Smoking is associated with poor clinical aspect and functional impairment in AS. The underlying mechanism can be the physical incapacity caused by smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Khan MA (1998) Ankylosing spondylitis: clinical features. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.16:1–10

  2. Lipsky PE (1998) Spondyloarthropathies: etiology and pathogenesis. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.12:1–8

  3. Ball GV (1993) Ankylosing spondylitis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions, 12th edn, vol 1. Lea and Febiger, Malvern, 59:1051–1060

  4. Wolheim FA (1993) Ankylosing spondylitis. In: Kelley WN, Harris ED, Ruddy S, Sledge C (eds) Textbook of rheumatology, 4th edn, vol 1. Saunders, Philadelphia, 56:943–960

  5. Claudepierre P, Sibilia J, Roudot-Thoraval F, Flipo RM, Wendling D et al ( 1998) Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 25:1927–1931

    CAS  PubMed  Google Scholar 

  6. Moller P (1987) Seronegative arthritis—etiology and diagnosis. Scand J Rheumatol Suppl 66:119–127

    CAS  PubMed  Google Scholar 

  7. Anonymous (1988) Public health survey on smoking. PIAR

  8. Garret S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    CAS  PubMed  Google Scholar 

  9. Calin A, Garret S, Whitlock H, Kennedy LG, O’Shea J, Mallorie P (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  10. Ward MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 29:1420–1425

    PubMed  Google Scholar 

  11. Fergusson DM, Goodwin RD, Horwood LJ (2003) Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 33:1357–1367

    Article  CAS  PubMed  Google Scholar 

  12. Berlin I, Singleton EG, Pedarriosse AM, Lancrenon S, Rames A, et al (2003) The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction 98:1575–1583

    Article  PubMed  Google Scholar 

  13. Arday DR, Milton MH, Husten CG, Haffer SC, Wheeless SC et al (2003) Smoking and functional status among Medicare managed care enrollees. Am J Prev Med 24:234–241

    Article  PubMed  Google Scholar 

  14. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedic K, Dawes (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138–142

    CAS  PubMed  Google Scholar 

  15. Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of long term outcome in ankylosing spondylitis. J Rheumatol 30:316–320

    PubMed  Google Scholar 

  16. Viitanen JV, Heikkila S, Kokko ML, Kautiainen H (2000) Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol 19:131–137

    Article  CAS  PubMed  Google Scholar 

  17. Dalyan M, Guner A, Tuncer S, Bilgic A, Arasil T (1999) Disability in ankylosing spondylitis. Disabil Rehabil 21:74–79

    CAS  PubMed  Google Scholar 

  18. Spoorenberg A, Van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:961–965

    CAS  PubMed  Google Scholar 

  19. Franssen MJ, Van de Putte LBA, Gribnau FWJ (1985) IgA serum levels and disease activity in ankylosing spondylitis. Ann Rheum Dis 44:766–771

    CAS  PubMed  Google Scholar 

  20. Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26:971–974

    CAS  PubMed  Google Scholar 

  21. Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524–528

    CAS  PubMed  Google Scholar 

  22. Van der Heijde D, Calin A, Dougados M, Khan MA, Van der Linden S, Bellamy N et al (1999) Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. J Rheumatol 26:951–954

    PubMed  Google Scholar 

  23. Fisher LR, Cawley MID, Holgate ST (1990) Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 49:921–925

    CAS  PubMed  Google Scholar 

  24. Harrison BJ, Silman AJ, Wiles NJ, Scott DG, Symmons DP (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323–330

    Article  CAS  PubMed  Google Scholar 

  25. Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A, Alldersea J, Fryer AA, Strange RC (2002) Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 46:640–646

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Özdemir Ferda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaan, U., Ferda, Ö. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 25, 357–360 (2005). https://doi.org/10.1007/s00296-004-0451-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0451-3

Keywords

Navigation